United Phosphorus, Inc. produces and sells crop protection products. The company supplies post patent technologies for the agricultural and specialty products industries. It offers agronomic tools such as post patent metribuzin, cypermethrin, bifenthrin and acephate products, and sugar beet herbicides. United Phosphorus is headquartered in Trenton, NJ

Arxada is a chemical solutions manufacturer. They provide combineering, microbial control solutions, specialty chemical services, hygiene, home, personal care, paints, coatings, material protection, wood protection, crop protection, CDMO, composite materials, performance intermediates, chemicals, and white biotech. The company also provides custom development, manufacturing organization, and performance intermediates and chemicals.

China State Institute of Pharmaceutical Industry is a company headquartered in Shanghai, China and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Farmoquímica SA manufactures and markets drugs. Its products are divided through the following therapeutic lines: allergy and immunology, angiology, cardiology, dermatology, general practice, obstetrics and gynecology, orthopaedics and traumatology, pediatrics, pulmonology and otorhinolaryngology. The company was founded in 1932 and is headquartered in Rio de Janeiro, Brazil.

Guangzhou Zhongda New Material Technology Co., Ltd., established on 2020-01-17, The scope of business includes the manufacture of plastic protective films;Plastic Film Manufacturing;Research and development of nanomaterials;Manufacturing of special machinery for the production of building materials;General Machinery Sales;Glass handicraft manufacturing;Glass fiber and product manufacturing;Manufacture of glass fiber reinforced plastic products;Manufacturing of technical glass products;Solar Technology Research,to develop,Technical Services;New material technical consultation,communication service;Import and export(Excluding franchised products);Technology Import and Export;Sales of packaging materials;Plastic Products Wholesale;

Stanley Agricultural Group Co., Ltd. engages in the research, development, production, and sale of compound fertilizers. Its products include micronutrient, granulation processed compound, nitro-compound, water-soluble, biological, slow-release, and seaweed fertilizers. The company also involves in the businesses of grain purchase & storage, agricultural information consultation, agricultural material trade, and agricultural services. Stanley Agricultural Group was founded in 1992 and is headquartered in Linyi, China.

Fibroheal Woundcare Pte Ltd. is a private company headquartered in Bangalore, India. The firm develops wound care management technology. It was founded in 2017.

Qingdao Haid Biological Group Co., Ltd., established on 2000-08-18, The scope of business includes the production of organic fertilizers(The validity period of the official fertilizer registration certificate is subject to the permit).Marine Bioengineering Technology Development,Research and development of marine chemical products,Transfer and production,Sales;Information Engineering Technology,Science and Technology Exchange,Incubation and transfer of technological achievements in environmental protection products and other fields,Technical Services,consult;Production and operation:Biological product,foliar fertilizer,flush fertilizer,compound fertilizer(Compound Fertilizers Only,blended fertilizer),water soluble fertilizer,organic-Inorganic Compound Fertilizer,Biological fertilizer,seaweed fertilizer,Medium element fertilizer,trace element fertilizer,solid seawater,soil conditioner(Production limited to branch operations);Fertilizer sales;Import and export of goods and technology;Labor service(Does not include overseas labor services);garbage disposal;Green Project,Garden maintenance;feed ingredients,R&D and sales of feed additives;fresh fruits and vegetables,flowers,Seeds and other agricultural products,food,Sales of gardening tools;Soil Remediation and Treatment;Realtor.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang Caihe Biotechnology Co., Ltd., established on 2019-12-17, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;Chemical product sales(No licensed chemical products);Instrument sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Experimental analysis instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following business segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computer, desktop monitors, tablets, and handheld devices. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists primarily of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary applications. The Specialty Materials segment engages in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Protemix Corporation is a biopharmaceutical company that discovers, develops and commercializes novel therapies for the prevention and treatment of cardiovascular disease, diabetes and other metabolic disorders and their complications. Through cost-effective research in New Zealand, the company has assembled a pipeline of novel and innovative compounds, The most advanced compound is in Phase 2b FDA trials for the treatment of diabetic heart failure.\nProtemix has assembled a pipeline of novel and innovative compounds, the most advanced of which is in Phase 2b FDA trials for the treatment of diabetic heart failure.\nProtemix’s discovery capabilities capitalize on the 30-year research expertise of the company’s founder, Professor Garth Cooper, a widely recognized expert in the field of peptide hormones, metabolic regulation and diabetes. The company’s discovery efforts are grounded in a detailed understanding of the potential mechanisms underlying diabetes and its complications, and have resulted in a pipeline of drug candidates that intervene at specific, well-defined disease targets to rebalance and renormalize key systems, thus enabling tissue repair and regeneration.\nProtemix’s lead compound, PX811019, is an orally active molecule that has shown the ability to reverse heart failure based on preclinical diabetic models and significantly reduced left ventricular hypertrophy in human clinic trials. Protemix studies suggest that PX811019 works by rebalancing abnormal copper accumulation in heart muscle, significantly improving cardiac structure and function without lowering blood glucose. The company has received Fast Track status for this compound from the U.S. Food and Drug Administration.\nThe company has a second compound, PX811013, in late preclinical development for the treatment of both alcohol-mediated and non-alcoholic liver damage. The Protemix pipeline also includes six preclinical discovery programs addressing significant market opportunities.\nProtemix has its commercialization activities and late stage clinical trials driven from San Diego, California with administrative offices in Auckland, New Zealand and research laboratories at the University of Auckland. The company, founded in 1999, is privately held.

Part of NOK Corp., Hokushin Corp. is a company headquartered in Yokohama, Japan. The firm manufactures precision functional elastic parts for automobiles, printers, and textile machineries. On March 19, 2004 NOK Corp. acquired Hokushin Corp.

For more than 60 years, Hach Company has developed innovative solutions used to test the quality of water, liquids and air. Manufactured and distributed worldwide, Hach systems are designed to simplify analysis by offering sophisticated on-line instrumentation, accurate portable laboratory equipment, high-quality prepared reagents, complete easy-to-follow methods, and life-time technical support.

Zhejiang NHU Company Ltd. provides solutions for animal and human nutrition, medicine, health, environmental protection, and engineering plastics worldwide. It offers ingredients, vitamins, carotenoids, aroma chemicals, polymers, flavors and fragrances, etc.; and APIs and intermediates covering various areas, such as cardiovascular, anti-aids, anti-cancer, and anti-bacterial.

Shandong Xinhecheng Amino Acid Co., Ltd., established on 2013-05-09, Business scope includes licensed projects:Feed additive production;Hazardous Chemical Production;Hazardous Chemicals Management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Feed Additive Sales;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Engage in investment activities with own funds;Engineering Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Qingdao Zhongtaihe Biotechnology Co., Ltd., established on 2016-04-27, Business scope includes marine life,Feed additives,Technology Development of Health Food,technology transfer,technical consulting,Technical Services;Biotechnology Extension Services;Sell ​​Feed Additives,feed,Chemical Products(Free of Hazardous Chemicals);Import and export;Technology Import and Export;Agent import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)